Blog - Page 3673 of 5714

ThursdayNov 11, 2010 9:15 am

BioMedical Technology Solutions (BMTL.OB) Reports Third Quarter Earnings; Revenues Up 107%, Expenses Down 38%

BioMedical Technology Solutions Holdings, Inc. reported its third quarter financial results as well as the 9-month period ended September 30, 2010 through a 10Q filed with the Security and Exchange Commission. BMTL is a provider of safe and environmentally sound medical waste disposal equipment for sharps and red bag waste that allows for medical waste to be processed, sterilized, labeled and then disposed of as common trash. The Company operates through its wholly-owned subsidiary, BioMedical Technology Solutions (“BMTS”). As with most developing companies, the company is operating at a loss, but there were many significant improvements in this most recent…

ThursdayNov 11, 2010 8:35 am

Simulated Environment Concepts, Inc. (SMEV.PK) to Exhibit SpaCapsule Product at International Hotel and Restaurant Conference

Simulated Environment Concepts, the manufacturer and developer of medical, aesthetic and wellness equipment, announced this morning that the company, with the support of French distributor Zen & O, will present their flagship product SpaCapsule at the Equip’Hôtel during an internationally renowned hospitality event. This year’s event marks the show’s 50th Anniversary and will be held at the International Rendezvous in Paris France, November 14 - 18, 2010. Zen & O, a major manufacturing partner of SE Concepts, will exhibit SpaCapsule’s H2O Body System. “This event should expand the growing interest in our health and wellness products shown by the global…

ThursdayNov 11, 2010 8:20 am

Consorteum Holdings, Inc.’s (CSRH.PK) MasterCard Benefits Program Continues to Move Forward

Consorteum Holdings, Inc. was pleased to announce today that its MasterCard benefits pilot program with the First Nations initiative in New Brunswick, Canada, has begun the second phase of implementation subsequent to the successful deployment among the community's administration group. Recently doubled in size to include additional community members, the pilot program is now accepting direct deposit of funds. The company will continue to collect the valuable data provided by the pilot to support the launch of a nationwide initiative. Recently obtaining the capital required for further expansion, Consorteum anticipates having sufficient data for a scheduled multi-location rollout in early…

WednesdayNov 10, 2010 3:32 pm

Gasco Energy, Inc. (GSX) is “One to Watch”

Gasco Energy, Inc., based in Denver, is a natural gas and petroleum exploitation, development and production company committed to locating and developing hydrocarbon resources in the Rocky Mountain area of the United Sates. The company currently focuses its drilling efforts in the Riverbend Project located in the Uinta Basin of northeastern Utah, targeting the Wasatch, Mesaverde, Blackhawk, Mancos, Dakota and Morrison formations. The company leverages technologies new to a specific area to generate and develop high-potential exploitation resources. Gasco Energy's business strategy encompases the acquisition of leasehold interests in petroleum and natural gas rights, either directly or indirectly, and the…

WednesdayNov 10, 2010 2:35 pm

Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB.OB) Secures $3.9M to Build Diosmin Plant, Massively Expanding Output to Meet Global Demand

Huifeng Bio-Pharmaceutical, www.hfgb.cn – the Chinese producer of flavonoids like rutin and other plant extracts/concentrated pharmaceutical raw materials, reported today entry into a $3.9M financing and construction agreement with Xi'an Jucheng Investment & Consulting Co., Ltd. (Jucheng). Jucheng is fully compliant with extant PRC laws and will provide $3.9M in financing under the agreement for the construction of a 500 ton/year Diosmin (another flavonoid) plant, designed from the ground up around the Chinese COS Standard. Subsequently, HFGB will issue 6.5M shares of its restricted common stock in consideration, 1.5M of which will stay restricted until HFGB approves the completed facility…

WednesdayNov 10, 2010 2:13 pm

eDoorways International Corp. (EDWY.PK) Offering The Latest Example Of Web 3.0

The underlying principle that seems to drive eDoorways is that users want a customized personalized environment when communicating on the Web. The idea that people want to choose what they see and hear is nothing new. The last 100 years in advertising has reflected a struggle to come up with a way to advertise only to those people that will really be interested, and that will therefore be likely to take action. The Internet has opened up new methods to focus this communication, matching the message to the person in ways never before possible. eDoorways allows people with a common…

WednesdayNov 10, 2010 11:14 am

DryShips, Inc. (DRYS) Video Chart for Wednesday, November 10, 2010

DRYS has been on a climb for the last week and made a sharp move yesterday on increased volume. A look at the 5-year weekly chart shows that the stock has strong possibilities of continuing the climb. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdayNov 10, 2010 10:05 am

Sunesis Pharmaceuticals, Inc. (SNSS) Provides Update Concerning Phase 2 Clinical Trials for Vosaroxin in AML

Today before the opening bell, Sunesis Pharmaceuticals, Inc. announced positive data from Phase 2 clinical trials of the company's lead drug candidate, vosaroxin, in combination with cytarabine, a widely used chemotherapy, in relapsed/refractory acute myeloid leukemia (AML) and as a single agent in frontline elderly AML. The data were presented today by Robert Stuart, M.D., Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, at the Chemotherapy Foundation Symposium XXVIII in New York City. The presentation is available to the public on the Sunesis website at www.sunesis.com. For the fully enrolled relapsed/refractory AML study, a…

WednesdayNov 10, 2010 9:43 am

CorMedix, Inc. (CRMD) Provides Third Quarter Update and Report

CorMedix, a biotechnology company with a focus on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, yesterday released its financial report for the third quarter ending September 30, 2010. While the Company’s financials were what is typically seen for developmental companies, there were some noteworthy highlights in the report. More specifically, the Company announced: • Appointment of Two Key Positions: Dr. Robert D. Hopkins as Head of Clinical Operations and Project Management and Mr. Dilip Wadgaonkar Head of Product Development and Manufacturing. • Continued Advancement of Patient Enrollment in Phase II Deferiprone CRMD001 for Prevention…

WednesdayNov 10, 2010 9:26 am

CDEX Inc. (CEXI.OB) to Launch Pocket ID2 Scanner

CDEX Inc. today announced the launch of its new Pocket ID2 Scanner, a device that detects trace amounts of illegal substances. In preparation for its launch, CDEX signed a distribution agreement with Lifeloc Technologies, a leading supplier of breath alcohol testers, to sell the Pocket ID2. The company expects to begin production in December 2010. CDEX’s product specializes in detecting illegal drugs, in particular methamphetamine. Studies by the National Survey on Drug Use and Health have estimated that Crystal Meth addiction is now the largest illegal drug pandemic gripping the nation. The results of a survey conducted in 2007 by…

Site Search

Company Search